PMC9131775_01
Clinical image of a 63-year-old woman showing bilateral conjunctival angioedema after the first dose of the adenovirus-vectored (ChAdOx1) SARS-Cov-2 vaccine. No reactions were recorded after the second homologous and third heterologous booster doses.
1678-9849-rsbmt-55-e0063-2022-gf1.jpg
PMC9131775_01_1678-9849-rsbmt-55-e0063-2022-gf1.jpg
f1
Nine hours later, she first noticed the emergence of bilateral conjunctival and facial angioedema (Figure 1) accompanied by local pruritus and a burning sensation.